Verification of the effect of long-term intake of Kamaboko on blood glucose levels.
Not Applicable
- Conditions
- Adult
- Registration Number
- JPRN-UMIN000052663
- Lead Sponsor
- iigata Bio-Research Park, Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1.Persons receiving treatment or medication for diabetes. 2.Persons who HbA1c 6.5% or higher. 3.Persons undergoing treatment for gastrointestinal diseases. 4.Persons undergoing treatment for cardiovascular disease. 5.Persons undergoing treatment for psychiatric disorders. 6.Pregnant and lactating women. 7.Persons with a history of allergic reactions to seafood, chicken eggs, wheat, or soybeans. 8.Persons who currently participating in another clinical trial or participated in one within the past 3 months. 9.Other persons deemed ineligible by the study investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method